ACVIM consensus guidelines for the diagnosis and treatment of myxomatous mitral valve disease in dogs

Journal of Veterinary Internal Medicine - Tập 33 Số 3 - Trang 1127-1140 - 2019
Bruce W. Keene1, Clarke E. Atkins1, John D. Bonagura1,2, Philip R. Fox3, Jens Häggström4, Virginia Luis Fuentes5, Mark A. Oyama6, John E. Rush7, Rebecca L. Stepien8, Masami Uechi9
1Department of Clinical Sciences, College of Veterinary Medicine, North Carolina State University, Raleigh, North Carolina
2Department of Veterinary Clinical Sciences, The Ohio State University, Columbus, Ohio
3The Elmer and Mamdouha Bobst Hospital, The Animal Medical Center New York New York
4Department of Clinical Sciences, Swedish University of Agricultural Sciences, Uppsala, Sweden
5Department of Clinical Science and Services Royal Veterinary College London United Kingdom
6Department of Clinical Sciences and Advanced Medicine University of Pennsylvania Philadelphia Pennsylvania
7Department of Clinical Sciences, Cummings School of Veterinary Medicine, Tufts University, North Grafton, Massachusetts
8Department of Medical Sciences, University of Wisconsin, Madison, Wisconsin
9Jasmine Veterinary Cardiovascular Medical Center Yokohama Japan

Tóm tắt

AbstractThis report, issued by the ACVIM Specialty of Cardiology consensus panel, revises guidelines for the diagnosis and treatment of myxomatous mitral valve disease (MMVD, also known as endocardiosis and degenerative or chronic valvular heart disease) in dogs, originally published in 2009. Updates were made to diagnostic, as well as medical, surgical, and dietary treatment recommendations. The strength of these recommendations was based on both the quantity and quality of available evidence supporting diagnostic and therapeutic decisions. Management of MMVD before the onset of clinical signs of heart failure has changed substantially compared with the 2009 guidelines, and new strategies to diagnose and treat advanced heart failure and pulmonary hypertension are reviewed.

Từ khóa


Tài liệu tham khảo

10.1016/j.jacc.2017.04.025

10.1111/j.1476-4431.2012.00758.x

10.1016/j.jvc.2012.02.001

10.1016/j.tvjl.2017.12.002

10.1093/jhered/esr041

10.1016/j.jvc.2012.01.011

10.1016/S1760-2734(06)70055-8

10.1016/j.cvsm.2010.03.008

10.1111/j.1748-5827.2009.00800.x

10.1111/j.1939-1676.1999.tb01462.x

10.1016/j.jvc.2012.01.005

10.2460/ajvr.69.6.763

10.1080/20013078.2017.1350088

10.1016/j.jcpa.2017.01.009

Markby G, 2017, Comparative transcriptomic profiling and gene expression for myxomatous mitral valve disease in the dog and human, Vet Sci, 4, 3,E34

10.2460/ajvr.2004.65.198

Han RI, 2010, Structural and cellular changes in canine myxomatous mitral valve disease: an image analysis study, J Heart Valve Dis, 19, 60

10.1016/j.carpath.2009.05.001

10.1111/jsap.12410

10.1136/vr.144.12.315

10.1097/00005344-199908000-00011

10.1016/j.rvsc.2015.03.020

10.1111/j.1939-1676.2009.0411.x

10.1016/j.jvc.2017.01.002

Buchanan JW, 1977, Chronic valvular disease (endocardiosis) in dogs, Adv Vet Sci Comp Med, 21, 75

10.1016/j.jvc.2014.11.001

10.1016/j.jvc.2014.08.002

10.1016/j.jvc.2012.01.003

10.1016/j.jvc.2012.01.008

10.1111/j.1939-1676.2011.00792.x

10.1016/j.jvc.2012.01.009

10.1111/j.1939-1676.2009.0392.x

10.1111/jvim.13663

10.1111/jvim.14619

10.1258/002367792780740512

10.1016/j.jvc.2014.03.001

10.1016/j.jvc.2012.12.005

10.1111/j.1939-1676.1992.tb00342.x

10.1111/j.1751-0813.2003.tb12881.x

10.1111/j.1740-8261.2007.00234.x

10.1016/j.jvc.2011.10.002

10.1016/j.jvc.2018.07.008

Boswood A, 2018, Die Wirkung von Pimobendan bei Hunden mit präklinischer myxomatöser Mitralklappenerkrankung und Kardiomegalie: Die EPIC‐Studie—Eine randomisierte klinische Studie, Kleintierpraxis, 62, 64

10.1111/jvim.14586

10.1111/j.1740-8261.2002.tb01051.x

10.1111/j.1939-1676.2004.tb02551.x

10.1136/vr.148.23.707

10.5326/JAAHA-MS-6474

10.1111/j.1748-5827.2007.00531.x

Choisunirachon N, 2008, Vertebral scale system to measure heart size in radiographs of Shih‐Tzus, Thai J Vet Med, 38, 60

10.1111/j.1740-8261.2012.01976.x

10.1111/j.1740-8261.2007.00252.x

10.1111/j.1740-8261.2005.00073.x

10.2460/javma.253.8.1038

10.1111/jvim.14885

10.1111/j.1939-1676.2006.tb00709.x

10.1111/j.1939-1676.2002.tb01610.x

10.2460/javma.231.7.1061

10.1111/j.1939-1676.2008.0105.x

10.1016/j.jvc.2017.06.001

10.1111/j.1748-5827.2012.01305.x

10.1016/j.jvc.2012.01.004

10.2460/javma.240.10.1194

10.2460/javma.232.10.1496

10.2460/javma.235.11.1319

10.1111/j.1939-1676.2003.tb02493.x

10.1016/j.jvc.2018.01.003

10.1111/j.1939-1676.2011.00800.x

10.1007/BF00880158

10.1111/j.1939-1676.1995.tb01074.x

10.1111/j.1939-1676.2007.tb02988.x

10.1111/j.1939-1676.1999.tb02164.x

10.1111/jvim.14841

10.1111/j.1939-1676.2009.0467.x

10.1016/j.jvc.2017.03.001

10.1111/j.1939-1676.2008.0150.x

10.5326/0420249

10.1016/j.tvjl.2015.08.017

10.1111/j.1939-1676.2010.0592.x

10.1111/jsap.12363

10.1111/jvim.14896

10.1111/j.1939-1676.2009.0301.x

10.1097/SPC.0b013e32833237f1

10.1111/j.1939-1676.2011.00838.x

10.1093/jn/132.6.1632S

10.1111/j.1939-1676.1998.tb02148.x

10.1111/j.1939-1676.2000.tb02269.x

10.3390/ijms160614098

10.2460/ajvr.68.10.1058

10.1111/j.1939-1676.2003.tb02529.x

10.1111/vec.12230

10.1016/j.jvc.2012.01.001

10.1016/j.jvc.2015.04.002

10.1016/j.jvc.2011.10.001

10.1111/j.1939-1676.2007.tb01947.x